Surgical staging not only identifies most patients with extrauterine disease but also identifies patients with uterine risk factors for recurrence, including large tumor size, deep myometrial invasion, cervical extension, and LVSI, thereby significantly impacting treatment decisions. Identification of these extrauterine and intrauterine risk factors allows for a more informed approach to the use of postoperative adjuvant therapy. It is hoped that this approach of surgical staging followed by postoperative targeted treatment will improve survival and spare many patients unnecessary exposure to radiation and/or chemotherapy.
|Original language||English (US)|
|Number of pages||10|
|Journal||American Journal of Oncology Review|
|State||Published - Mar 1 2006|
ASJC Scopus subject areas